Skip to main content

Table 2 Characteristics of Combination therapy

From: The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study

Characteristic

Total n (%)

Capecitabine

1 (6.3)

S-1

8 (50.0)

Oxaliplatin

1 (6.3)

Irinotecan

2 (12.2)

PD-1 inhibitor

4 (25.0)

  1. PD-1 Programmed cell death-1
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us